top of page
Search
IN VITRO REVOLUTION
Alzheimer's Disease
Idiopathic Pulmonary Fibrosis
Congenital Heart Disease
Type 1 Diabetes Mellitus
Inflammatory Bowel Disease
Amyotrophic Lateral Sclerosis
Thrombocytopenia
Chronic Skin Wounds
INDUSTRY NEWS
Product Launches
Intra-industry Partnerships
M&A Activity
Grants Awarded & Funds Raised
Pharma & Biotech Collaborations
Clinical Trial Authorizations
Regulatory Modernization
TECH FRONTIERS
APPLICATION EXPLORER
Log In
Subscribe to Newsletter
All Posts
Organ-on-a-chip systems
Intra-industry partnerships
Pharma & biotech collaborations
Product Launches
Clinical Trial Outcomes
M&A Activity
Bioprinting
3D tissue platforms
Clinical Trial Authorizations
Regulatory Modernizations
Organoid technologies
Grants Awarded & Funds Raised
Hybrid AI-in vitro platforms
Organo Therapeutics' brain organoids enable mechanistic elucidation of Priavoid's drug candidate for synucleinopathies
Pharma & biotech collaborations
Bioengineered directoids enable in vitro probing of information flow between human brain regions
Organoid technologies
28bio launches CNS-3D myelinated organoids to predict therapeutic efficacy
Product Launches
3D immuno-glial-neurovascular human brain platform for high-fidelity disease modelling
3D tissue platforms
Emulate launches Brain-Chip R1, first-in-class comprehensive neurovascular unit
Product Launches
bottom of page